CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: We present evidence that PTL and DMAPT are able to abrogate bulk CML cells and a primitive CML population (CD34+lin−) by a mechanism dependent on ROS induction and NF‐κB pathway inhibition.